Atrioventricular Conduction Disturbance Characterization in Transcatheter Aortic Valve Implantation With the CoreValve Prosthesis
- 1 June 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 4 (3) , 280-286
Abstract
Background—: Atrioventricular (AV) block is one of the most frequent complications of CoreValve transcatheter aortic valve implantation (TAVI). The aim of this study was to analyze the effects of CoreValve implantation on AV conduction. Methods and Results—: Electrophysiological study was performed immediately before and after CoreValve implantation in 18 consecutive, permanent pacemaker-free patients. An electrode was placed on the His bundle during valve implantation, and data were continuously recorded during the procedure. With surface ECG, a median (first, third quartile) QRS width of 96 (84, 116) to 150 (121, 164) ms ( P =0.001) and PR interval of 180 (159, 216) to 210 (190, 240) ms ( P =0.008) were significantly prolonged, and QRS axis was left deviated 30° (−32°, 46°) to −20° (−60°, 2°) ( P =0.005). With intracardiac electrograms, the AH (97 [70, 123] to 115 [96, 135] ms, P =0.021) and HV (52 [42, 55] to 60 [50, 70] ms, P =0.002) intervals were increased. At the end of the procedure, we observed significant ECG- or electrophysiological study-persistent conduction disturbances in 14 (78%) patients. Five patients experienced transient changes (2 AV blocks and 3 left bundle branch blocks). Conclusions—: CoreValve implantation worsens AV conduction in most patients, either transiently or permanently. This worsening is the result of direct damage either on the His bundle or on the AV node.Keywords
This publication has 25 references indexed in Scilit:
- “Device landing zone” calcification, assessed by MSCT, as a predictive factor for pacemaker implantation after TAVICatheterization and Cardiovascular Interventions, 2010
- Incidence and Predictors of Permanent Pacemaker Requirement after Transcatheter Aortic Valve Implantation with a Self-Expanding BioprosthesisPacing and Clinical Electrophysiology, 2010
- Progress and Current Status of Percutaneous Aortic Valve Replacement: Results of Three Device Generations of the CoreValve Revalving SystemCirculation: Cardiovascular Interventions, 2008
- ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm AbnormalitiesJACC, 2008
- Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosisThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving™ SystemCatheterization and Cardiovascular Interventions, 2007
- Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm AssociationEuropean Heart Journal, 2007
- Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve DiseaseCirculation, 2006
- Correlates of prolonged HV conduction in aortic stenosisAmerican Heart Journal, 1985
- HV interval in calcific aortic stenosis. Relation to left ventricular function and effect of valve replacement.Heart, 1984